Natural Killer T-cell Lymphoma Nasal Type
📧 Sign up to get email alerts when something new happens for Natural Killer T-cell Lymphoma Nasal Type.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: Sintilimab, Pegaspargase and Anlotinib for Stage IV Natural Killer /T-cell Lymphoma [Phase 2]
Phase 2 clinical trial update evaluating sintilimab, pegylated asparaginase (pegaspargase), and anlotinib for stage IV Natural Killer / T-ce…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Treatment of Relapsed or Refractory Natural Killer/T Cell Lymphoma [Phase 2]
Phase 2 clinical trial update for treatment of relapsed or refractory natural killer/T-cell lymphoma, nasal type.